Philippe Moreau, Pieter Sonneveld, Hermann Einsele, Hang Quach, P. Joy Ho, Meral Beksac, Cyrille Hulin, Elisabetta Antaonioli, Xavier P. Leleu, Silvia Mangiacavalli, Aurore Perrot, Michele Cavo, Angelo Belotti, Annemiek Broijl, Huiling Pei, Anna Sitthi-Amorn, Robin L. Carson, Meletios Athanasios Dimopoulos, Paula Rodriguez-Otero, Mario Boccadoro. "Subcutaneous daratumumab (Dara) + bortezomib/lenalidomide/dexamethasone (VRd) with Dara + lenalidomide (DR) maintenance in transplant-eligible (TE) patients with newly diagnosed multiple myeloma (NDMM): Analysis of sustained minimal residual disease negativity in the phase 3 PERSEUS trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7501